{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:16:21Z","timestamp":1782926181548,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004513","name":"Harry Crossley Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["ZAMPOLI9KO"],"award-info":[{"award-number":["ZAMPOLI9KO"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jcf.2023.09.003","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T02:28:28Z","timestamp":1694485708000},"page":"334-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Global disparities in cystic fibrosis outcomes prior to CFTR modulators: A CF registries cohort study in South Africa and Canada"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6899-6137","authenticated-orcid":false,"given":"Marco","family":"Zampoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1148-4747","authenticated-orcid":false,"given":"Janine","family":"Verstraete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2890-8451","authenticated-orcid":false,"given":"Stephanie Y.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5193-918X","authenticated-orcid":false,"given":"Brenda","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6406-2380","authenticated-orcid":false,"given":"Michael S.","family":"Pepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9046-759X","authenticated-orcid":false,"given":"Heather J.","family":"Zar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jcf.2023.09.003_bib0001","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jcf.2017.11.013","article-title":"Epidemiology of CF: how registries can be used to advance our understanding of the CF population","volume":"17","author":"Jackson","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2023.09.003_bib0002","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jcf.2017.11.014","article-title":"A guide to interpreting estimated median age of survival in cystic fibrosis patient registry reports","volume":"17","author":"Keogh","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"17","key":"10.1016\/j.jcf.2023.09.003_bib0003","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jcf.2023.09.003_bib0004","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jcf.2020.07.017","article-title":"Projecting the impact of delayed access to elexacaftor\/tezacaftor\/ivacaftor for people with cystic fibrosis","volume":"20","author":"Stanojevic","year":"2021","journal-title":"J Cyst Fibrosis"},{"issue":"1","key":"10.1016\/j.jcf.2023.09.003_bib0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2023.09.003_bib0006","article-title":"Extensive CFTR sequencing through NGS in Brazilian individuals with cystic fibrosis: unravelling regional discrepancies in the country","author":"da Silva","year":"2020","journal-title":"J Cyst Fibrosis"},{"issue":"7","key":"10.1016\/j.jcf.2023.09.003_bib0007","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/gim.2015.157","article-title":"Cystic fibrosis on the African continent","volume":"18","author":"Stewart","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.jcf.2023.09.003_bib0008","unstructured":"Worldometer; available at https:\/\/www.worldometers.info\/world-population\/south-africa-population\/; accesssed 25 April 2020."},{"issue":"3","key":"10.1016\/j.jcf.2023.09.003_bib0009","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00856-2020","article-title":"Cystic fibrosis in South Africa: spectrum of disease and determinants of outcome","volume":"7","author":"Zampoli","year":"2021","journal-title":"ERJ Open Res"},{"issue":"4","key":"10.1016\/j.jcf.2023.09.003_bib0010","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/ppul.25810","article-title":"Trends in cystic fibrosis survival over 40 years in South Africa: an observational cohort study","volume":"57","author":"Zampoli","year":"2022","journal-title":"Pediatr Pulmonol"},{"issue":"S48","key":"10.1016\/j.jcf.2023.09.003_bib0011","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1002\/ppul.23790","article-title":"Data that empower: the success and promise of CF patient registries","volume":"52","author":"Fink","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"10.1016\/j.jcf.2023.09.003_bib0012","doi-asserted-by":"crossref","first-page":"537","DOI":"10.7326\/M16-0858","article-title":"Survival comparison of patients with cystic fibrosis in Canada and the United States: a population-based cohort study","volume":"166","author":"Stephenson","year":"2017","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.jcf.2023.09.003_bib0013","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.healun.2020.12.001","article-title":"Bridging the survival gap in cystic fibrosis: an investigation of lung transplant outcomes in Canada and the United States","volume":"40","author":"Stephenson","year":"2021","journal-title":"J Heart Lung Transpl"},{"issue":"6","key":"10.1016\/j.jcf.2023.09.003_bib0014","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2023.09.003_bib0015","doi-asserted-by":"crossref","unstructured":"Smith S.J., Gray D.M., MacGinty R.P., Hall G.L., Stanojevic S., Mphahlele R., Masekela R. Medicine cc. Choosing the better global lung initiative 2012 equation in South African population groups. 2020;202(12):1724\u20137.","DOI":"10.1164\/rccm.202005-2085LE"},{"key":"10.1016\/j.jcf.2023.09.003_bib0016","unstructured":"WHO AnthroPlus for personal computers manual: software for assessing growth of the world's children and adolescents. Geneva: WHO, 2009 available at: http:\/\/www.who.int\/growthref\/tools\/en\/."},{"issue":"4","key":"10.1016\/j.jcf.2023.09.003_bib0017","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0895-4356(00)00321-8","article-title":"Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores","volume":"54","author":"Normand","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jcf.2023.09.003_bib0018","series-title":"Multiple imputation for nonresponse in surveys","author":"Toutenburg","year":"1987"},{"issue":"3","key":"10.1016\/j.jcf.2023.09.003_bib0019","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02288-2020","article-title":"Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study","volume":"58","author":"McKone","year":"2021","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jcf.2023.09.003_bib0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1513\/AnnalsATS.202010-1274ED","article-title":"Social inequities and cystic fibrosis outcomes: we can do better","volume":"18","author":"Oates","year":"2021","journal-title":"Ann Am Thorac Soc."},{"key":"10.1016\/j.jcf.2023.09.003_bib0021","unstructured":"World bank GDP per capita data: avaialble at: https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD; accessed 19 May 2023."},{"issue":"5","key":"10.1016\/j.jcf.2023.09.003_bib0022","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jcf.2018.06.006","article-title":"Using registry data to improve quality of care","volume":"17","author":"McIntyre","year":"2018","journal-title":"J Cyst Fibrosis"},{"issue":"6","key":"10.1016\/j.jcf.2023.09.003_bib0023","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1164\/rccm.201707-1541OC","article-title":"Comparison of nutrition and lung function outcomes in patients with cystic fibrosis living in Canada and the United States","volume":"197","author":"Goss","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.jcf.2023.09.003_bib0024","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.jcf.2023.09.003_bib0025","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jcf.2022.04.007","article-title":"Current prices versus minimum costs of production for CFTR modulators","volume":"21","author":"Guo","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.09.003_bib0026","unstructured":"Robbins S.N.R. 2023 Miracle cystic fibrosis drug kept out of reach in developing countries; available at: https:\/\/www.nytimes.com\/2023\/02\/07\/health\/cystic-fibrosis-drug-trikafta.html?smid=url-share. New York Times 72023 7 February."},{"issue":"1","key":"10.1016\/j.jcf.2023.09.003_bib0027","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/ijns6010018","article-title":"Newborn screening for CF across the globe\u2014where is it worthwhile?","volume":"6","author":"Scotet","year":"2020","journal-title":"Int J Neonatal Screen"},{"issue":"10","key":"10.1016\/j.jcf.2023.09.003_bib0028","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/ppul.23774","article-title":"A new insight into CFTR allele frequency in Brazil through next generation sequencing","volume":"52","author":"Nunes","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.jcf.2023.09.003_bib0029","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/ijns8010008","article-title":"Successful Implementation of Expanded Newborn Screening in the Philippines Using Tandem Mass Spectrometry","volume":"8","author":"Padilla","year":"2022","journal-title":"Int J Neonatal Screen"},{"issue":"4","key":"10.1016\/j.jcf.2023.09.003_bib0030","doi-asserted-by":"crossref","DOI":"10.24953\/turkjped.2019.04.006","article-title":"Two years of newborn screening for cystic fibrosis in Turkey: \u00e7ukurova experience","volume":"61","author":"Sasihuseyinoglu","year":"2019","journal-title":"Turk J Pediatr"},{"issue":"1","key":"10.1016\/j.jcf.2023.09.003_bib0031","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/jmg.36.1.41","article-title":"Cystic fibrosis carrier frequencies in populations of African origin","volume":"36","author":"Padoa","year":"1999","journal-title":"J Med Genet"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323009074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323009074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T08:23:06Z","timestamp":1772353386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199323009074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1569199323009074"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.09.003","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global disparities in cystic fibrosis outcomes prior to CFTR modulators: A CF registries cohort study in South Africa and Canada","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}